 James McManaman
Concepts (417)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lipid Metabolism | 23 | 2020 | 525 | 4.630 |
Why?
| | Lactation | 25 | 2020 | 219 | 4.600 |
Why?
| | Mammary Glands, Animal | 21 | 2019 | 183 | 4.390 |
Why?
| | Milk | 13 | 2019 | 139 | 3.550 |
Why?
| | Perilipin-2 | 15 | 2022 | 52 | 3.210 |
Why?
| | Membrane Proteins | 12 | 2016 | 1081 | 1.960 |
Why?
| | Mammary Glands, Human | 8 | 2020 | 79 | 1.630 |
Why?
| | Diet, High-Fat | 9 | 2019 | 267 | 1.480 |
Why?
| | Cytoplasm | 7 | 2016 | 283 | 1.470 |
Why?
| | Xanthine Dehydrogenase | 7 | 2016 | 38 | 1.450 |
Why?
| | Non-alcoholic Fatty Liver Disease | 5 | 2022 | 288 | 1.370 |
Why?
| | Dietary Fats | 7 | 2018 | 353 | 1.360 |
Why?
| | Obesity | 10 | 2019 | 2709 | 1.320 |
Why?
| | Lipid Droplets | 4 | 2022 | 23 | 1.260 |
Why?
| | Liver | 8 | 2020 | 1852 | 1.130 |
Why?
| | Fatty Liver | 6 | 2018 | 277 | 1.090 |
Why?
| | Lipids | 8 | 2022 | 636 | 1.080 |
Why?
| | Hepatocytes | 2 | 2019 | 204 | 1.040 |
Why?
| | Endoplasmic Reticulum | 4 | 2019 | 252 | 1.040 |
Why?
| | Glycolipids | 2 | 2016 | 39 | 1.020 |
Why?
| | Mice | 41 | 2022 | 15530 | 0.890 |
Why?
| | Glycoproteins | 2 | 2016 | 325 | 0.890 |
Why?
| | Organelles | 2 | 2013 | 57 | 0.880 |
Why?
| | Cell Membrane | 5 | 2016 | 728 | 0.850 |
Why?
| | Animals | 57 | 2022 | 34332 | 0.820 |
Why?
| | Electron Microscope Tomography | 1 | 2019 | 38 | 0.750 |
Why?
| | Metabolic Diseases | 3 | 2018 | 113 | 0.740 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 2019 | 12 | 0.730 |
Why?
| | Xanthine Oxidase | 6 | 2004 | 86 | 0.720 |
Why?
| | Mice, Inbred C57BL | 14 | 2022 | 5137 | 0.710 |
Why?
| | Carbohydrate Metabolism | 1 | 2018 | 52 | 0.690 |
Why?
| | Adipose Tissue, White | 1 | 2018 | 41 | 0.680 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 4 | 2016 | 64 | 0.670 |
Why?
| | Adipose Tissue, Brown | 1 | 2018 | 72 | 0.650 |
Why?
| | Breast Feeding | 2 | 2018 | 375 | 0.630 |
Why?
| | Apocrine Glands | 1 | 2016 | 5 | 0.620 |
Why?
| | Peptides | 3 | 2008 | 874 | 0.610 |
Why?
| | Gene Deletion | 1 | 2018 | 368 | 0.610 |
Why?
| | Ovarian Diseases | 1 | 2016 | 12 | 0.600 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2016 | 48 | 0.600 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2018 | 170 | 0.580 |
Why?
| | Infertility | 1 | 2016 | 45 | 0.580 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2016 | 132 | 0.560 |
Why?
| | Temperature | 1 | 2018 | 616 | 0.550 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2014 | 42 | 0.530 |
Why?
| | Ovary | 1 | 2016 | 210 | 0.520 |
Why?
| | Fatty Acids | 4 | 2022 | 417 | 0.510 |
Why?
| | Gastrointestinal Microbiome | 3 | 2020 | 477 | 0.510 |
Why?
| | Milk, Human | 3 | 2020 | 154 | 0.490 |
Why?
| | Mothers | 2 | 2018 | 662 | 0.460 |
Why?
| | Obstetric Labor, Premature | 2 | 2011 | 41 | 0.440 |
Why?
| | Adipose Tissue | 5 | 2019 | 665 | 0.440 |
Why?
| | Fatty Liver, Alcoholic | 1 | 2011 | 18 | 0.420 |
Why?
| | Diet | 1 | 2018 | 1116 | 0.400 |
Why?
| | Proteomics | 3 | 2016 | 806 | 0.400 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 524 | 0.390 |
Why?
| | Protein Folding | 2 | 2011 | 251 | 0.380 |
Why?
| | Phospholipids | 1 | 2011 | 205 | 0.370 |
Why?
| | Female | 35 | 2020 | 63228 | 0.350 |
Why?
| | Mice, Knockout | 7 | 2022 | 2805 | 0.340 |
Why?
| | Body Fluids | 1 | 2008 | 66 | 0.340 |
Why?
| | Ethanol | 2 | 2011 | 727 | 0.320 |
Why?
| | Gene Expression Regulation | 7 | 2018 | 2525 | 0.320 |
Why?
| | Recombinant Fusion Proteins | 5 | 2011 | 672 | 0.320 |
Why?
| | Pregnancy | 12 | 2020 | 5540 | 0.320 |
Why?
| | Caseins | 2 | 2011 | 25 | 0.300 |
Why?
| | Vagina | 1 | 2008 | 154 | 0.300 |
Why?
| | Proteins | 2 | 2013 | 912 | 0.300 |
Why?
| | Perilipin-1 | 3 | 2019 | 19 | 0.300 |
Why?
| | Aldehyde Oxidoreductases | 3 | 2000 | 44 | 0.280 |
Why?
| | Insulin Resistance | 4 | 2019 | 1163 | 0.270 |
Why?
| | Alcohol Drinking | 1 | 2011 | 711 | 0.270 |
Why?
| | Promoter Regions, Genetic | 3 | 2011 | 1219 | 0.270 |
Why?
| | Epithelial Cells | 6 | 2020 | 989 | 0.260 |
Why?
| | Nerve Tissue Proteins | 4 | 1996 | 584 | 0.260 |
Why?
| | Diet, Fat-Restricted | 2 | 2015 | 80 | 0.260 |
Why?
| | Protein Structure, Tertiary | 4 | 2011 | 840 | 0.250 |
Why?
| | Proteome | 2 | 2013 | 323 | 0.250 |
Why?
| | Diet, Western | 2 | 2022 | 67 | 0.250 |
Why?
| | Protein C | 1 | 2003 | 38 | 0.240 |
Why?
| | Remyelination | 1 | 2022 | 8 | 0.230 |
Why?
| | Chromatography, Affinity | 3 | 1999 | 92 | 0.230 |
Why?
| | Bile Acids and Salts | 2 | 2022 | 183 | 0.230 |
Why?
| | Oxidoreductases | 1 | 2002 | 95 | 0.210 |
Why?
| | Sp1 Transcription Factor | 1 | 2000 | 25 | 0.200 |
Why?
| | Sevelamer | 1 | 2020 | 10 | 0.200 |
Why?
| | Feces | 3 | 2020 | 366 | 0.200 |
Why?
| | Homeodomain Proteins | 2 | 2017 | 496 | 0.190 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2008 | 107 | 0.190 |
Why?
| | Gene Silencing | 1 | 2000 | 180 | 0.190 |
Why?
| | Phosphoproteins | 3 | 2013 | 315 | 0.190 |
Why?
| | HEK293 Cells | 2 | 2013 | 656 | 0.190 |
Why?
| | Prolactin | 1 | 2000 | 107 | 0.190 |
Why?
| | Rats | 9 | 2019 | 6014 | 0.180 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2004 | 309 | 0.180 |
Why?
| | Animals, Newborn | 4 | 2016 | 846 | 0.180 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2018 | 499 | 0.180 |
Why?
| | Adipocytes | 2 | 2018 | 195 | 0.180 |
Why?
| | Biological Transport | 2 | 2014 | 406 | 0.170 |
Why?
| | Perilipin-3 | 2 | 2008 | 5 | 0.170 |
Why?
| | Thermogenesis | 1 | 2018 | 48 | 0.170 |
Why?
| | Male | 14 | 2022 | 60409 | 0.170 |
Why?
| | Reproduction | 1 | 1999 | 200 | 0.170 |
Why?
| | Lipogenesis | 1 | 2018 | 80 | 0.170 |
Why?
| | Energy Metabolism | 5 | 2017 | 920 | 0.170 |
Why?
| | Computational Biology | 1 | 2020 | 481 | 0.160 |
Why?
| | Humans | 29 | 2020 | 117481 | 0.160 |
Why?
| | Hydrocortisone | 1 | 2000 | 332 | 0.160 |
Why?
| | Glucose | 3 | 2019 | 925 | 0.160 |
Why?
| | Butyrophilins | 1 | 2016 | 5 | 0.160 |
Why?
| | Adiposity | 2 | 2015 | 504 | 0.150 |
Why?
| | Fibroblast Growth Factors | 1 | 2018 | 178 | 0.150 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2017 | 483 | 0.150 |
Why?
| | Intracellular Membranes | 1 | 2016 | 78 | 0.150 |
Why?
| | Protein Structure, Secondary | 2 | 2011 | 345 | 0.150 |
Why?
| | Litter Size | 1 | 2016 | 19 | 0.150 |
Why?
| | Metabolic Networks and Pathways | 2 | 2017 | 175 | 0.150 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 285 | 0.150 |
Why?
| | Mice, Obese | 1 | 2016 | 60 | 0.150 |
Why?
| | Spinal Cord | 2 | 1991 | 400 | 0.150 |
Why?
| | Drosophila Proteins | 1 | 2017 | 179 | 0.140 |
Why?
| | Triglycerides | 4 | 2011 | 551 | 0.140 |
Why?
| | Feeding Behavior | 2 | 2018 | 557 | 0.140 |
Why?
| | Carrier Proteins | 3 | 2008 | 759 | 0.140 |
Why?
| | Intestines | 2 | 2015 | 320 | 0.130 |
Why?
| | Receptors, Cell Surface | 3 | 2005 | 374 | 0.130 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 33 | 0.130 |
Why?
| | Transcription Factors | 3 | 2010 | 1623 | 0.130 |
Why?
| | Weight Gain | 1 | 2018 | 513 | 0.130 |
Why?
| | Inflammation | 3 | 2022 | 2537 | 0.130 |
Why?
| | DNA-Binding Proteins | 2 | 2005 | 1382 | 0.130 |
Why?
| | RNA-Binding Proteins | 1 | 2017 | 363 | 0.130 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.130 |
Why?
| | Molecular Sequence Data | 5 | 2000 | 2896 | 0.120 |
Why?
| | Transfection | 2 | 2008 | 910 | 0.120 |
Why?
| | Betaine | 1 | 2013 | 66 | 0.120 |
Why?
| | Disease Models, Animal | 3 | 2020 | 3800 | 0.120 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2014 | 157 | 0.120 |
Why?
| | Protein Binding | 3 | 2011 | 2016 | 0.120 |
Why?
| | Isoproterenol | 1 | 2013 | 146 | 0.120 |
Why?
| | Models, Biological | 3 | 2011 | 1764 | 0.120 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2022 | 2028 | 0.120 |
Why?
| | Mice, Transgenic | 4 | 2006 | 2102 | 0.110 |
Why?
| | Microfilament Proteins | 1 | 2013 | 128 | 0.110 |
Why?
| | Nuclear Proteins | 1 | 2017 | 623 | 0.110 |
Why?
| | Sex Factors | 1 | 2018 | 1921 | 0.110 |
Why?
| | Transcriptome | 1 | 2017 | 729 | 0.110 |
Why?
| | Sciatic Nerve | 1 | 1992 | 65 | 0.110 |
Why?
| | Body Weight | 2 | 2015 | 991 | 0.110 |
Why?
| | Cholesterol | 3 | 2022 | 392 | 0.110 |
Why?
| | Macrophages | 1 | 2019 | 1330 | 0.110 |
Why?
| | Vacuoles | 1 | 2011 | 33 | 0.110 |
Why?
| | Cell Line | 4 | 2008 | 2832 | 0.110 |
Why?
| | Protein Processing, Post-Translational | 2 | 2008 | 424 | 0.110 |
Why?
| | Morphogenesis | 1 | 2012 | 179 | 0.110 |
Why?
| | Microbiota | 1 | 2017 | 538 | 0.110 |
Why?
| | Adenoviruses, Human | 1 | 2011 | 26 | 0.100 |
Why?
| | Lipase | 1 | 2011 | 76 | 0.100 |
Why?
| | Mice, Mutant Strains | 2 | 2011 | 293 | 0.100 |
Why?
| | Fructose | 1 | 2013 | 203 | 0.100 |
Why?
| | Microtubules | 1 | 2013 | 241 | 0.100 |
Why?
| | Aldehyde Oxidase | 3 | 2000 | 6 | 0.100 |
Why?
| | Lipid Peroxidation | 1 | 2011 | 157 | 0.100 |
Why?
| | Cell Differentiation | 4 | 2007 | 1790 | 0.100 |
Why?
| | Membranes, Artificial | 1 | 2011 | 78 | 0.100 |
Why?
| | Receptor, IGF Type 1 | 1 | 2010 | 63 | 0.100 |
Why?
| | Receptor, ErbB-3 | 1 | 2010 | 45 | 0.100 |
Why?
| | Binding Sites | 3 | 2003 | 1259 | 0.090 |
Why?
| | Amino Acid Sequence | 4 | 1999 | 2106 | 0.090 |
Why?
| | Phosphorylation | 2 | 2013 | 1678 | 0.090 |
Why?
| | Genetic Vectors | 1 | 2011 | 312 | 0.090 |
Why?
| | Green Fluorescent Proteins | 1 | 2011 | 408 | 0.090 |
Why?
| | Milk Proteins | 2 | 2007 | 44 | 0.090 |
Why?
| | Guidelines as Topic | 1 | 2011 | 282 | 0.090 |
Why?
| | Genetic Therapy | 1 | 2011 | 269 | 0.090 |
Why?
| | Isoenzymes | 3 | 1999 | 320 | 0.090 |
Why?
| | Benzamidines | 2 | 1999 | 3 | 0.090 |
Why?
| | Oleic Acid | 1 | 2008 | 40 | 0.090 |
Why?
| | Metabolic Syndrome | 1 | 2013 | 394 | 0.090 |
Why?
| | Receptors, Progesterone | 2 | 2001 | 324 | 0.090 |
Why?
| | Mutant Proteins | 1 | 2008 | 102 | 0.090 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2008 | 135 | 0.080 |
Why?
| | Cattle | 3 | 2002 | 950 | 0.080 |
Why?
| | Mutation | 3 | 2017 | 3406 | 0.080 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2010 | 685 | 0.080 |
Why?
| | Biomarkers | 1 | 2018 | 3574 | 0.080 |
Why?
| | Receptor, ErbB-2 | 1 | 2010 | 318 | 0.080 |
Why?
| | Child Development | 1 | 2012 | 469 | 0.080 |
Why?
| | Structure-Activity Relationship | 1 | 2008 | 530 | 0.080 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 47 | 0.080 |
Why?
| | Pancreas, Exocrine | 1 | 2006 | 11 | 0.080 |
Why?
| | Breast Neoplasms | 4 | 2010 | 1926 | 0.080 |
Why?
| | Electrolytes | 1 | 2006 | 65 | 0.080 |
Why?
| | Salivary Glands | 1 | 2006 | 37 | 0.080 |
Why?
| | RNA, Messenger | 6 | 2006 | 2748 | 0.080 |
Why?
| | Chromatography, Liquid | 1 | 2008 | 337 | 0.070 |
Why?
| | Trypsin | 2 | 2002 | 72 | 0.070 |
Why?
| | Thermodynamics | 1 | 2008 | 395 | 0.070 |
Why?
| | Cluster Analysis | 2 | 2008 | 477 | 0.070 |
Why?
| | Cholinergic Fibers | 1 | 1985 | 21 | 0.070 |
Why?
| | Tandem Mass Spectrometry | 1 | 2008 | 389 | 0.070 |
Why?
| | Neoadjuvant Therapy | 1 | 2008 | 312 | 0.070 |
Why?
| | Ciliary Neurotrophic Factor | 3 | 1996 | 10 | 0.070 |
Why?
| | Models, Molecular | 1 | 2011 | 1482 | 0.070 |
Why?
| | Peptide Fragments | 3 | 2003 | 718 | 0.070 |
Why?
| | Base Sequence | 3 | 2000 | 2170 | 0.070 |
Why?
| | Serine Endopeptidases | 1 | 1985 | 99 | 0.070 |
Why?
| | Gestational Age | 1 | 2008 | 786 | 0.070 |
Why?
| | Chronic Disease | 1 | 2011 | 1667 | 0.070 |
Why?
| | Models, Animal | 1 | 2006 | 380 | 0.070 |
Why?
| | Time Factors | 5 | 2003 | 6905 | 0.070 |
Why?
| | Enzyme Induction | 2 | 2003 | 99 | 0.060 |
Why?
| | Milk Ejection | 1 | 2003 | 1 | 0.060 |
Why?
| | Recombinant Proteins | 3 | 2003 | 1317 | 0.060 |
Why?
| | Antibodies, Monoclonal | 1 | 2010 | 1266 | 0.060 |
Why?
| | Pregnancy, Animal | 1 | 2003 | 63 | 0.060 |
Why?
| | Up-Regulation | 1 | 2006 | 900 | 0.060 |
Why?
| | Phagocytes | 1 | 2003 | 98 | 0.060 |
Why?
| | Homozygote | 1 | 2003 | 190 | 0.060 |
Why?
| | Diabetes Mellitus | 2 | 2011 | 962 | 0.060 |
Why?
| | COS Cells | 1 | 2003 | 194 | 0.060 |
Why?
| | Tyrosine | 1 | 2003 | 239 | 0.060 |
Why?
| | Hormones | 1 | 2003 | 134 | 0.060 |
Why?
| | Chromatography | 1 | 2002 | 28 | 0.060 |
Why?
| | Sequence Deletion | 1 | 2003 | 180 | 0.060 |
Why?
| | Chymotrypsin | 1 | 2002 | 20 | 0.060 |
Why?
| | Transgenes | 1 | 2003 | 190 | 0.060 |
Why?
| | Species Specificity | 1 | 2004 | 594 | 0.060 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 173 | 0.060 |
Why?
| | Receptors, Nerve Growth Factor | 2 | 1992 | 18 | 0.060 |
Why?
| | Diabetic Nephropathies | 1 | 2005 | 290 | 0.050 |
Why?
| | Protein Conformation | 2 | 2002 | 880 | 0.050 |
Why?
| | Phenylalanine | 1 | 2002 | 69 | 0.050 |
Why?
| | Disulfides | 1 | 2002 | 95 | 0.050 |
Why?
| | Methionine | 1 | 2002 | 151 | 0.050 |
Why?
| | Transforming Growth Factor beta | 2 | 2020 | 469 | 0.050 |
Why?
| | Cross-Linking Reagents | 1 | 2002 | 183 | 0.050 |
Why?
| | Signal Transduction | 4 | 2017 | 4824 | 0.050 |
Why?
| | Myelin Sheath | 1 | 2022 | 144 | 0.050 |
Why?
| | Cysteine | 1 | 2002 | 200 | 0.050 |
Why?
| | Sp3 Transcription Factor | 1 | 2000 | 8 | 0.050 |
Why?
| | Flavoproteins | 1 | 2000 | 7 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2002 | 344 | 0.050 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2022 | 224 | 0.050 |
Why?
| | Gene Expression Profiling | 2 | 2008 | 1594 | 0.050 |
Why?
| | Iron-Sulfur Proteins | 1 | 2000 | 28 | 0.050 |
Why?
| | Lactobacillus | 1 | 2020 | 26 | 0.050 |
Why?
| | Cecum | 1 | 2020 | 40 | 0.050 |
Why?
| | Fibrosis | 1 | 2022 | 458 | 0.050 |
Why?
| | Metalloproteins | 1 | 1999 | 6 | 0.050 |
Why?
| | Genistein | 1 | 2000 | 23 | 0.050 |
Why?
| | Lysine | 1 | 2002 | 237 | 0.050 |
Why?
| | Molybdenum | 1 | 1999 | 10 | 0.050 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2002 | 507 | 0.050 |
Why?
| | Microscopy, Fluorescence | 1 | 2002 | 421 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2008 | 2942 | 0.050 |
Why?
| | Microscopy, Electron | 1 | 2000 | 427 | 0.050 |
Why?
| | Sulfhydryl Compounds | 1 | 2002 | 182 | 0.050 |
Why?
| | Antigens, Surface | 1 | 2000 | 163 | 0.050 |
Why?
| | NAD | 1 | 1999 | 51 | 0.050 |
Why?
| | Flavonoids | 1 | 2000 | 71 | 0.050 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 128 | 0.050 |
Why?
| | Kinetics | 3 | 2001 | 1685 | 0.050 |
Why?
| | Epidermal Growth Factor | 1 | 2000 | 165 | 0.050 |
Why?
| | Collagen Type I | 1 | 2020 | 134 | 0.050 |
Why?
| | Alcohol Dehydrogenase | 1 | 1999 | 23 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 199 | 0.040 |
Why?
| | Rats, Inbred Strains | 2 | 1992 | 470 | 0.040 |
Why?
| | Proto-Oncogene Proteins | 1 | 2003 | 682 | 0.040 |
Why?
| | Postpartum Period | 1 | 2020 | 268 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2000 | 321 | 0.040 |
Why?
| | Transcriptional Activation | 1 | 2000 | 371 | 0.040 |
Why?
| | Kidney | 1 | 2005 | 1236 | 0.040 |
Why?
| | Transcription, Genetic | 3 | 2001 | 1409 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2011 | 400 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 3 | 2003 | 2855 | 0.040 |
Why?
| | Sequence Analysis, DNA | 1 | 2000 | 706 | 0.040 |
Why?
| | DNA | 2 | 2000 | 1359 | 0.040 |
Why?
| | Cytokines | 2 | 2003 | 1946 | 0.040 |
Why?
| | Enzyme Inhibitors | 2 | 2003 | 874 | 0.040 |
Why?
| | Oxygen | 1 | 2002 | 865 | 0.040 |
Why?
| | Mass Spectrometry | 1 | 2000 | 685 | 0.040 |
Why?
| | Autoantigens | 1 | 2000 | 407 | 0.040 |
Why?
| | Isoelectric Point | 1 | 1996 | 23 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 1997 | 220 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2020 | 1133 | 0.040 |
Why?
| | Sepharose | 1 | 1996 | 36 | 0.040 |
Why?
| | Solubility | 2 | 2000 | 245 | 0.040 |
Why?
| | Larva | 1 | 2017 | 216 | 0.040 |
Why?
| | DNA Damage | 1 | 1999 | 372 | 0.040 |
Why?
| | Tumor Cells, Cultured | 2 | 1997 | 920 | 0.040 |
Why?
| | Cachexia | 1 | 1996 | 50 | 0.040 |
Why?
| | Stem Cells | 1 | 2020 | 537 | 0.040 |
Why?
| | Oncogene Protein pp60(v-src) | 1 | 1995 | 6 | 0.040 |
Why?
| | Adult | 3 | 2020 | 32104 | 0.040 |
Why?
| | Drosophila melanogaster | 1 | 2017 | 195 | 0.040 |
Why?
| | Polymerase Chain Reaction | 2 | 1999 | 1017 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1205 | 0.030 |
Why?
| | Phenotype | 1 | 2003 | 2868 | 0.030 |
Why?
| | Receptors, GABA-A | 1 | 1995 | 114 | 0.030 |
Why?
| | Choline O-Acetyltransferase | 1 | 1994 | 24 | 0.030 |
Why?
| | Muscle, Skeletal | 2 | 2011 | 1539 | 0.030 |
Why?
| | Escherichia coli | 3 | 1995 | 788 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 1996 | 1144 | 0.030 |
Why?
| | Islets of Langerhans | 1 | 2000 | 715 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2008 | 770 | 0.030 |
Why?
| | Chromatography, Gel | 2 | 2000 | 132 | 0.030 |
Why?
| | Plasmids | 1 | 1994 | 380 | 0.030 |
Why?
| | Endopeptidases | 2 | 2000 | 75 | 0.030 |
Why?
| | Hep G2 Cells | 1 | 2013 | 77 | 0.030 |
Why?
| | Molecular Weight | 2 | 2000 | 350 | 0.030 |
Why?
| | Fructokinases | 1 | 2013 | 64 | 0.030 |
Why?
| | Nerve Crush | 1 | 1992 | 7 | 0.030 |
Why?
| | PC12 Cells | 1 | 1992 | 40 | 0.030 |
Why?
| | Aldehyde Reductase | 1 | 2013 | 104 | 0.030 |
Why?
| | Metrizamide | 1 | 1991 | 2 | 0.030 |
Why?
| | Curare | 1 | 1991 | 4 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2000 | 1787 | 0.030 |
Why?
| | Centrifugation, Density Gradient | 1 | 1991 | 45 | 0.030 |
Why?
| | Culture Techniques | 1 | 1991 | 90 | 0.030 |
Why?
| | Cell Fractionation | 1 | 1991 | 55 | 0.030 |
Why?
| | Blotting, Northern | 1 | 1992 | 195 | 0.030 |
Why?
| | Nerve Regeneration | 1 | 1992 | 51 | 0.030 |
Why?
| | Chick Embryo | 1 | 1991 | 146 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 880 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2877 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2003 | 4191 | 0.030 |
Why?
| | Lipolysis | 1 | 2011 | 50 | 0.030 |
Why?
| | Ear | 1 | 2011 | 30 | 0.030 |
Why?
| | Response Elements | 2 | 2001 | 84 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2012 | 336 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2010 | 69 | 0.020 |
Why?
| | Trastuzumab | 1 | 2010 | 95 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2010 | 171 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2010 | 165 | 0.020 |
Why?
| | Estrogen Receptor Modulators | 1 | 2008 | 20 | 0.020 |
Why?
| | Polymers | 1 | 2013 | 470 | 0.020 |
Why?
| | S100 Proteins | 1 | 2008 | 38 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2011 | 1253 | 0.020 |
Why?
| | RNA Interference | 1 | 2010 | 490 | 0.020 |
Why?
| | Palmitates | 1 | 2007 | 25 | 0.020 |
Why?
| | Lactose | 1 | 2007 | 10 | 0.020 |
Why?
| | PPAR alpha | 1 | 2007 | 59 | 0.020 |
Why?
| | Tamoxifen | 1 | 2008 | 208 | 0.020 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2007 | 63 | 0.020 |
Why?
| | Trans-Activators | 1 | 2010 | 400 | 0.020 |
Why?
| | Blotting, Western | 1 | 2010 | 1247 | 0.020 |
Why?
| | Endopeptidase K | 1 | 1985 | 14 | 0.020 |
Why?
| | Subtilisins | 1 | 1985 | 8 | 0.020 |
Why?
| | Biomedical Research | 1 | 2012 | 598 | 0.020 |
Why?
| | Sterol Regulatory Element Binding Protein 2 | 1 | 2005 | 9 | 0.020 |
Why?
| | L-Lactate Dehydrogenase | 1 | 1985 | 120 | 0.020 |
Why?
| | PPAR gamma | 1 | 2007 | 192 | 0.020 |
Why?
| | Receptors, Leptin | 1 | 2005 | 28 | 0.020 |
Why?
| | Membrane Transport Proteins | 1 | 2006 | 146 | 0.020 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 38 | 0.020 |
Why?
| | Nerve Growth Factors | 1 | 1985 | 72 | 0.020 |
Why?
| | Research Design | 1 | 2011 | 969 | 0.020 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2010 | 651 | 0.020 |
Why?
| | Proteinuria | 1 | 2005 | 103 | 0.020 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2005 | 93 | 0.020 |
Why?
| | Acetylcholine | 1 | 1985 | 204 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2008 | 387 | 0.020 |
Why?
| | Hyperlipidemias | 1 | 2005 | 144 | 0.020 |
Why?
| | Tungsten | 1 | 2003 | 25 | 0.020 |
Why?
| | Metformin | 1 | 2007 | 291 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1755 | 0.020 |
Why?
| | Allopurinol | 1 | 2003 | 86 | 0.020 |
Why?
| | Deoxyglucose | 1 | 2003 | 53 | 0.020 |
Why?
| | Stromal Cells | 1 | 2003 | 105 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2000 | 348 | 0.010 |
Why?
| | Transduction, Genetic | 1 | 2003 | 125 | 0.010 |
Why?
| | Brain | 1 | 1995 | 2697 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2005 | 507 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 2898 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2005 | 588 | 0.010 |
Why?
| | Biomarkers, Tumor | 1 | 2008 | 1048 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2012 | 5226 | 0.010 |
Why?
| | Ultracentrifugation | 1 | 2001 | 55 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2003 | 441 | 0.010 |
Why?
| | Pulmonary Alveoli | 1 | 2003 | 394 | 0.010 |
Why?
| | Chromatography, Ion Exchange | 1 | 2000 | 53 | 0.010 |
Why?
| | Detergents | 1 | 2000 | 46 | 0.010 |
Why?
| | Clone Cells | 1 | 2000 | 243 | 0.010 |
Why?
| | Interferon-gamma | 1 | 2003 | 740 | 0.010 |
Why?
| | Alkaline Phosphatase | 1 | 1980 | 155 | 0.010 |
Why?
| | Mice, SCID | 1 | 2000 | 353 | 0.010 |
Why?
| | Hypoglycemic Agents | 1 | 2007 | 1026 | 0.010 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2000 | 161 | 0.010 |
Why?
| | Infant | 1 | 2012 | 8243 | 0.010 |
Why?
| | Interleukin-1 | 1 | 2003 | 1027 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1999 | 263 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2010 | 2015 | 0.010 |
Why?
| | Mice, Inbred NOD | 1 | 2000 | 579 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 381 | 0.010 |
Why?
| | Cycloheximide | 1 | 1997 | 61 | 0.010 |
Why?
| | Pneumonia | 1 | 2003 | 577 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1999 | 556 | 0.010 |
Why?
| | 3T3 Cells | 1 | 1997 | 147 | 0.010 |
Why?
| | DNA Primers | 1 | 1999 | 551 | 0.010 |
Why?
| | Denervation | 1 | 1996 | 24 | 0.010 |
Why?
| | Nervous System | 1 | 1996 | 69 | 0.010 |
Why?
| | Muscular Atrophy | 1 | 1996 | 85 | 0.010 |
Why?
| | Reactive Oxygen Species | 1 | 1999 | 585 | 0.010 |
Why?
| | GABA-A Receptor Agonists | 1 | 1995 | 17 | 0.010 |
Why?
| | Muscimol | 1 | 1995 | 34 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 1999 | 957 | 0.010 |
Why?
| | Radioisotopes | 1 | 1995 | 35 | 0.010 |
Why?
| | Organ Size | 1 | 1996 | 492 | 0.010 |
Why?
| | Mice, Inbred ICR | 1 | 1995 | 116 | 0.010 |
Why?
| | Chlorine | 1 | 1995 | 60 | 0.010 |
Why?
| | Xenopus laevis | 1 | 1995 | 163 | 0.010 |
Why?
| | Liposomes | 1 | 1995 | 161 | 0.010 |
Why?
| | Apoptosis | 1 | 2003 | 2572 | 0.010 |
Why?
| | Lung | 1 | 2003 | 3641 | 0.010 |
Why?
| | Risk Factors | 1 | 1999 | 9124 | 0.000 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2000 | 3253 | 0.000 |
Why?
|
|
McManaman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|